Oncology PracticePembrolizumab improves 5-year OS in advanced NSCLCJune 6, 2019Lung CancerImmuno-oncology
Oncology PracticePembro as good as chemo for gastric cancers with less toxicityJune 1, 2019GastroenterologyImmuno-oncologyGastrointestinal Cancer
Hematology NewsLow intensity bridging may be best path to CAR T in adult ALLJune 1, 2019ALLCellular TherapyLeukemia, Myelodysplasia, TransplantationImmuno-oncologyImmunotherapy
Oncology PracticePembro with or without chemo superior to EXTREME for advanced HNSCCJune 1, 2019Head & Neck/Thyroid CancersImmuno-oncology
Oncology PracticeNovel anti-PD-1 antibody can be given subcutaneouslyMay 31, 2019Immuno-oncologyImmunotherapyHead & Neck/Thyroid Cancers
Oncology PracticeDo some EGFR mutation subtypes benefit from immune checkpoint blockade?May 17, 2019Lung CancerImmuno-oncology
Oncology PracticeCMS proposes payment increase for administering CAR T in the hospitalMay 3, 2019Practice ManagementImmuno-oncologyBusiness of MedicineCellular Therapy
Oncology PracticeMyc signaling, monocytes predict NSCLC response to second-line entinostat + pembroMay 2, 2019Lung CancerImmuno-oncology
Oncology PracticeSRA737 + anti–PD-L1 therapy and low-dose gemcitabine shows early promise for SCLCApril 30, 2019Lung CancerImmuno-oncologyGI Oncology
Oncology PracticeHigh pCR rate in HPV+ HNSCC with nivolumab/SBRTApril 30, 2019Head & Neck/Thyroid CancersImmuno-oncology
Oncology PracticeMYSTIC trial: bTMB correlates with tTMB, predicts survival in mNSCLCApril 30, 2019Lung CancerImmuno-oncology
Hematology NewsICYMI: NIH renames, streamlines gene therapy committeeApril 26, 2019Cellular TherapyBusiness of MedicineAnemiaImmuno-oncologyImmunotherapyGene Therapy
Lessons from KEYNOTE-158 and the role of R-CHOPApril 25, 2019Gynecologic CancerB Cell LymphomaImmuno-oncology
Hematology NewsMonitoring, early intervention key to CAR T safetyApril 24, 2019Cellular TherapyAggressive LymphomasImmunotherapyB Cell LymphomaTransplantationImmuno-oncologyLymphoma & Plasma Cell Disorders
Oncology PracticePACIFIC: Patient-reported outcomes unaffected by PD-L1 expressionApril 23, 2019Lung CancerImmuno-oncology
